AUD 0.12
(-8.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 11.97 Million AUD | 165.55% |
2022 | 4.51 Million AUD | -21.91% |
2021 | 5.77 Million AUD | 400.95% |
2020 | 1.15 Million AUD | 1970.89% |
2019 | 55.67 Thousand AUD | 1054.6% |
2018 | 4822.00 AUD | 141.97% |
2017 | -11.49 Thousand AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 3.47 Million AUD | 35.83% |
2024 Q1 | 2.55 Million AUD | -37.92% |
2023 Q2 | 3.83 Million AUD | 48.11% |
2023 FY | 11.97 Million AUD | 165.55% |
2023 Q1 | 2.58 Million AUD | 0.0% |
2023 Q4 | 4.11 Million AUD | 67.6% |
2023 Q3 | 2.45 Million AUD | -35.94% |
2022 Q2 | 2.24 Million AUD | -30.52% |
2022 Q1 | 3.22 Million AUD | 100.44% |
2022 FY | 4.51 Million AUD | -21.91% |
2022 Q3 | 2.24 Million AUD | 0.0% |
2021 FY | 5.77 Million AUD | 400.95% |
2021 Q4 | 1.6 Million AUD | -36.38% |
2021 Q3 | 2.52 Million AUD | 777.48% |
2021 Q1 | 641.15 Thousand AUD | 100.0% |
2021 Q2 | 288.24 Thousand AUD | -55.04% |
2020 FY | 1.15 Million AUD | 1970.89% |
2020 Q4 | 320.58 Thousand AUD | -37.36% |
2020 Q3 | 511.81 Thousand AUD | 100.0% |
2020 Q2 | 255.9 Thousand AUD | 193.24% |
2020 Q1 | 87.26 Thousand AUD | 100.0% |
2019 Q3 | -21.25 Thousand AUD | -415.81% |
2019 Q2 | 6729.00 AUD | 0.0% |
2019 Q4 | 43.63 Thousand AUD | 305.32% |
2019 FY | 55.67 Thousand AUD | 1054.6% |
2018 FY | 4822.00 AUD | 141.97% |
2017 FY | -11.49 Thousand AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Althea Group Holdings Limited | 2.13 Million AUD | -461.802% |
Cann Group Limited | 3.19 Million AUD | -274.886% |
ECS Botanics Holdings Ltd | 7.51 Million AUD | -59.437% |
Ecofibre Limited | -1.08 Million AUD | 1208.012% |
Elixinol Wellness Limited | -1.8 Million AUD | 763.947% |
Hygrovest Limited | 260 Thousand AUD | -4506.774% |
IDT Australia Limited | 6.7 Million AUD | -78.717% |
Invion Limited | 1 Million AUD | -1093.894% |
Live Verdure Ltd | 695.99 Thousand AUD | -1620.939% |
Medical Developments International Limited | -2.5 Million AUD | 579.104% |
Vitura Health Limited | 34.21 Million AUD | 64.998% |
Vita Life Sciences Limited | 42.6 Million AUD | 71.886% |